IRISH JIAN (Chief Executive Officer) received a stock award from METAGENOMI THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2026ACC: 0001193125-26-141946
DirectorOfficer· Chief Executive Officer
Since Dec 2025
+322K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
322K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+46K
Price / share
—
Trade value
—
% of position
13.8%
4/1/2026
333.77K→379.77K
Total
Net shares
+46K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | A · Award | +46K | — | — | 13.8% | 333.77K | 379.77K |
| Total | +46K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
276K shares
Shares
+276K
Strike price
1.34
Held after
276K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock276K shares | 4/1/2026 | A · Award | +276K | 1.34 | — | 276K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned292.71K
Common Stock
IndirectShares owned292.71K
Total
585.43K indirect585.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 292.71K | Indirect |
| Common Stock | 292.71K | Indirect |
| Total | 585.43K | 585.43K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported